Summary
The product Primo 100, Test E 150 mg/ml, submitted by Axle Labs, underwent independent testing to verify its authenticity and potency. The manufacturer details were not provided, and the sample was identified by batch number C54 exp 09/2027. The sample was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control, and tested for the presence of Methenolone Enanthate, Testosterone Enanthate, and Guaiacol.
The testing process began on 26 July 2024, with the sample received on 30 July 2024, and analysis completed on 3 August 2024. The analysis confirmed the presence of Methenolone Enanthate at 112.31 mg/ml and Testosterone Enanthate at 170.19 mg/ml, both exceeding their respective expected concentrations of 100 mg/ml and 150 mg/ml, while Guaiacol was not detected. This suggests a slightly higher-than-expected dosing of the active ingredients. Independent third-party testing remains essential to ensure consistency and product reliability across different batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Axle Labs
- Product Name: Primo 100, Test E 150 mg/ml
- Active Ingredients:
- Methenolone Enanthate
- Testosterone Enanthate
- Batch Number: C54 exp 09/2027
- Expiration Date: September 2027
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #46245
- Testing Ordered: 26 July 2024
- Sample Received: 30 July 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Axle Labs
- Analysis Paid For By: Axle Labs
Testing Results
- Specification:
- Methenolone Enanthate: 100 mg/ml (expected)
- Testosterone Enanthate: 150 mg/ml (expected)
- Measured Concentration:
- Methenolone Enanthate: 112.31 mg/ml
- Testosterone Enanthate: 170.19 mg/ml
- Guaiacol: Not detected
Verification Details
Verification URL: https://janoshik.com/tests/46245_T4M7EEKQ9E4U
Evaluation of Submitted Testing
This analysis confirms the presence of Methenolone Enanthate and Testosterone Enanthate in Primo 100, Test E 150 mg/ml, with both measured concentrations exceeding the expected label amounts. While this suggests high potency, the lack of manufacturer details and batch oversight necessitates further scrutiny to ensure consistency across multiple samples. The absence of Guaiacol, a commonly used solvent, may affect product viscosity and injection properties. Janoshik Analytical is recognized for its transparency and rigorous testing protocols; however, further third-party validation is recommended.
Conclusion
The analysis confirms that Primo 100, Test E 150 mg/ml contains Methenolone Enanthate at 112.31 mg/ml and Testosterone Enanthate at 170.19 mg/ml, both exceeding their expected concentrations, while Guaiacol was not detected. This suggests high potency but highlights the importance of further testing to ensure formulation consistency across batches. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
